Compare PRPO & HOLO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PRPO | HOLO |
|---|---|---|
| Founded | N/A | 2018 |
| Country | United States | China |
| Employees | N/A | 74 |
| Industry | Biotechnology: Laboratory Analytical Instruments | Computer Software: Programming Data Processing |
| Sector | Industrials | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.1M | 43.3M |
| IPO Year | 2000 | N/A |
| Metric | PRPO | HOLO |
|---|---|---|
| Price | $20.97 | $1.49 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 100.9K | ★ 291.1K |
| Earning Date | 05-12-2026 | 08-10-2023 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 92.15 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,049,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.16 |
| Revenue Growth | ★ 29.77 | N/A |
| 52 Week Low | $13.80 | $1.43 |
| 52 Week High | $33.63 | $7.03 |
| Indicator | PRPO | HOLO |
|---|---|---|
| Relative Strength Index (RSI) | 35.19 | 44.30 |
| Support Level | $19.01 | $1.43 |
| Resistance Level | $25.98 | $1.67 |
| Average True Range (ATR) | 1.84 | 0.10 |
| MACD | -0.35 | 0.01 |
| Stochastic Oscillator | 22.54 | 22.64 |
Precipio Inc is a healthcare biotechnology company focused on cancer diagnostics. Its objective is to enhance diagnostic accuracy & accessibility while building a sustainable business model that supports ongoing innovation. The company operates Clinical Laboratory Improvement Amendments laboratories in both New Haven, Connecticut, & Omaha, Nebraska, providing essential blood cancer diagnostics to office-based oncologists in many states nationwide. The company operates in a single segment, which includes two divisions: the Pathology Services Division & the Products Division. The Pathology Services provides specialized cancer diagnostic testing services. The pathology services division specializes in diagnostic testing focused mainly on hematologic cancers.
MicroCloud Hologram Inc provides holographic technology services. Its services include holographic light detection and ranging (LiDAR) solutions, holographic LiDAR point cloud algorithms architecture design, technical holographic imaging solutions, holographic LiDAR sensor chip design, and holographic vehicle intelligent vision technology to service customers that provide holographic driver assistance systems (ADAS). The company also provides holographic digital twin technology services for customers and has built a proprietary holographic digital twin technology resource library. MicroCloud's operating segments are: Holographic technology service, which generates maximum revenue, and Holographic solutions. Its revenues are mainly generated in the People's Republic of China (PRC).